The Significance of Breast Cancer–Driving Mutations in Noncoding Genomic Regions
A recent analysis of 360 primary breast cancer genomes has identified some potentially important cancer-driving mutations found within noncoding genomic regions.
Novel Quadruplet Therapy Shows Promise in Multiple Myeloma
In this interview with Charlotte Pawlyn, MB, BChir, PhD, she discusses results of the Myeloma XI study, which tested a novel quadruplet therapy for patients with newly diagnosed multiple myeloma.
Next-Generation Sequencing for Sarcoma
We spoke with Mrinal M. Gounder, MD, about next-generation sequencing for sarcoma, and how it can be used to inform treatment decisions and prognosis.
Lung Cancer Immunotherapy Updates From ASCO
In this podcast interview, Dr. Hossein Borghaei discusses some of the latest science presented at ASCO that focuses on immunotherapy in lung cancer.
Novel Nanomedicine Development for Glioblastoma
We spoke with Dr. Priya Kumthekar and Dr. Alexander Stegh about their nucleic acid-based therapeutic development that targets glioblastoma.
Incorporating Immunotherapy-Related Biomarkers Into Clinical Practice
Dr. Karen Reckamp talks about ways to incorporate biomarkers for the treatment of lung cancer with immunotherapy into clinical practice at the 2017 American Society of Clinical Oncology Annual Meeting, held June 2–6 in Chicago.
A Multidisciplinary Approach to Treating Immune-Related Adverse Events
We spoke with Monica Fradkin on ways to help minimize adverse events in patients receiving immunotherapy treatment at the Oncology Nursing Society 42nd Annual Congress, held May 4–7 in Denver.
By clicking Accept, you agree to become a member of the UBM Medica Community.